These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Follow-up study of tolmetin users. Jick H; Jick SS; Hunter JR; Walker AM Pharmacotherapy; 1989; 9(2):91-4. PubMed ID: 2726592 [TBL] [Abstract][Full Text] [Related]
66. Stomatitis associated with zomepirac. Bates LH; Triplett WC; Berry ER; Weddle RA JAMA; 1982 Jan 22-29; 247(4):461-2. PubMed ID: 7054543 [No Abstract] [Full Text] [Related]
67. Zomepirac-induced serum sickness. A report of two cases. Kiani R; Kushner M JAMA; 1983 May; 249(20):2812-3. PubMed ID: 6842791 [TBL] [Abstract][Full Text] [Related]
68. [Nephrogenic diabetes insipidus possibly secondary to the ingestion of sodium zomepirac dihydrate]. Llinares Mondéjar P; Sesma Sánchez P; Amador Barciela L; Suárez Sambade D; Martínez Debén F; Agulló García M Med Clin (Barc); 1983 Oct; 81(12):546. PubMed ID: 6656373 [No Abstract] [Full Text] [Related]
69. Response of rheumatoid arthritis with leukopenia to gold salts. Gowans JD; Salami M N Engl J Med; 1973 May; 288(19):1007-8. PubMed ID: 4633144 [No Abstract] [Full Text] [Related]
70. Enhancement of deficient T-cell function in rheumatoid arthritis by tolmetin sodium. Levy J J Clin Pharmacol; 1983 Jul; 23(7):324-8. PubMed ID: 6604073 [TBL] [Abstract][Full Text] [Related]
71. Near fatal bronchospasm induced by zomepirac sodium. Ross SR; Friedman CJ; Lesnefsky EJ Ann Allergy; 1982 Apr; 48(4):233-4. PubMed ID: 7073027 [No Abstract] [Full Text] [Related]
72. Drugs in the management of rheumatoid arthritis. Bresnihan B Ir Med J; 1982 Jan; 75(1):7-9. PubMed ID: 6806208 [No Abstract] [Full Text] [Related]
73. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. Davis P; Menard H; Thompson J; Harth M; Beaudet F J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393 [TBL] [Abstract][Full Text] [Related]
74. [Side effects of gold salt therapy in patients with rheumatoid arthritis]. Vlak T; Jajić I Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149 [TBL] [Abstract][Full Text] [Related]
75. [Gold therapy of rheumatic diseases]. Berndt H Z Arztl Fortbild (Jena); 1987; 81(9):416. PubMed ID: 3114970 [No Abstract] [Full Text] [Related]
76. Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis. Levinson JE; Baum J; Brewer E; Fink C; Hanson V; Schaller J J Pediatr; 1977 Nov; 91(5):799-804. PubMed ID: 333079 [TBL] [Abstract][Full Text] [Related]
77. Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1978 Jun; 15(6):429-50. PubMed ID: 350558 [No Abstract] [Full Text] [Related]
78. Tolmetin: an evaluation of a new preparation in the treatment of rheumatoid arthritis. Bain LS; el-Ghobarey AF; Collins RM; Sargent NW Br J Clin Pract; 1975 Aug; 29(8):208-10. PubMed ID: 1100086 [No Abstract] [Full Text] [Related]
79. Government affairs. FDA Arthritis Advisory Committee Meeting. Paulus HE Arthritis Rheum; 1983 Nov; 26(11):1397-8. PubMed ID: 6196034 [No Abstract] [Full Text] [Related]
80. Clinical evaluation of tolmetin. Brooks PM; Watkins CF; Sturrock RD; Lee P Curr Med Res Opin; 1974; 2(6):323-8. PubMed ID: 4448098 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]